Slavcho Dimitrov

Slavcho Dimitrov

Auto-generated profile, based on publicly available information

Slavcho Dimitrov

Oncology, TEVA Pharmaceuticals, Amsterdam, Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012
Verified
Conference Paper
Closed access
PDF file
VKVeselin Kussovski
Veselin Kussovski
Vanya MantarevaVanya Mantareva
Vanya Mantareva
IAIltcho Angelov
Iltcho Angelov
LALachezar A Avramov
Lachezar A Avramov
EPE V Popova
E V Popova
SDSlavcho Dimitrov
Slavcho Dimitrov
The Gram-negative, oral bacterium Aggregatibacter actinomycetemcomitans has been implicated as the causative agent of several forms of periodontal disease in humans. The new periodontal disease treatments are emergence in order to prevent infection progression. Antimicrobial photodynamic therapy (a-PDT) can be a useful tool for this purpose. It involves the use of light of specific wavelength to activate a nontoxic photosensitizing agent in the presence of oxygen for eradication of target cells, and appears effective in photoinactivation of microorganisms. The phthalocyanine metal complexes of Pd(II)- (PdPcC) and Al(III)- (AlPc1) were evaluated as photodynamic sensitizers towards a dental pathogen A. actinomycetemcomitans in comparison to the known methylpyridyloxy-substituted Zn(II) phthalocyanine (ZnPcMe). The planktonic and biofilm-cultivated species of A. actinomycetemcomitans were treated. The photophysical results showed intensive and far-red absorbance with high tendency of aggregation for Pd(II)-phthalocyanine. The dark toxicities of both photosensitizers were negligible at concentrations used (< 0.5 log decrease of viable cells). The photodynamic response for planktonic cultured bacteria was full photoinactivation after a-PDT with ZnPcMe. In case of the newly studied complexes, the effect was lower for PdPcC (4 log) as well as for AlPc1 (1.5-2 log). As it is known the bacterial biofilms were more resistant to a-PDT, which was confirmed for A. actinomycetemcomitans biofilms with 3 log reductions of viable cells after treatment with ZnPcMe and approximately 1 log reduction of biofilms after PdPcC and AlPc1. The initial results suggest that a-PDT can be useful for effective inactivation of dental pathogen A. actinomycetemcomitans.

1 January 2015
Verified
Journal Article
Closed access
ATA Tonev
A Tonev
SDS Dimitrov
S Dimitrov
TZT Zahariev
T Zahariev
GNG Nachev
G Nachev

1 January 2010
Verified
Journal Article
Closed access
ATA Tonev
A Tonev
SDS Dimitrov
S Dimitrov
TZT Zahariev
T Zahariev
GNG Nachev
G Nachev

1 January 2010
Verified
Journal Article
Closed access
ATA Tonev
A Tonev
SDS Dimitrov
S Dimitrov
TZT Zahariev
T Zahariev
GNG Nachev
G Nachev

1 January 2013
Verified
Journal Article
Closed access
ATA Tonev
A Tonev
SDSvetoslav Dimitrov
Svetoslav Dimitrov
TZT Zahariev
T Zahariev
GNG Nachev
G Nachev

1 September 2021 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
HLHartmut Link
Hartmut Link
STS.F. Thompson
S.F. Thompson
MTM. Tian
M. Tian
DMD. Meise
D. Meise
JHJ.S. Haas
J.S. Haas
SDS. Dimitrov
S. Dimitrov
We assessed the occurrence of febrile neutropenia (FN) events and the associated healthcare resource use and costs of cancer patients receiving myelosuppressive chemotherapy in combination with pegfilgrastim (PEG) versus lipegfilgrastim (LI-PEG).